DO-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DO-2, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours [Phase 1]